Chiral ligands are used with metal catalysts to transfer chirality and create new chiral centers in molecules undergoing asymmetric synthesis. Chiral induction refers to the formation of an excess of one enantiomer over the other from an achiral or racemic substrate using a chiral catalyst or reagent. Examples of drugs synthesized through homogeneous catalysis using chiral ligands include L-DOPA, (R)-naproxen, S-ibuprofen, and (R)-citronellal.